Woodline Partners LP Cullinan Oncology, Inc. Transaction History

Woodline Partners LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$9.72 - $13.62 $1.9 Million - $2.67 Million	195,839 New	195,839 $2.07 Million
Q2 2022 Aug 15, 2022	BUY	$7.31 - $13.55 $2.51 Million - $4.65 Million	343,514 Added 72.31%	818,572 $10.5 Million
Q3 2021 Nov 15, 2021	SELL	$22.56 - $29.68 $1.94 Million - $2.56 Million	-86,148 Reduced 15.35%	475,058 $10.7 Million
Q2 2021 Aug 16, 2021	BUY	$24.96 - $41.25 $456,618 - $754,627	18,294 Added 3.37%	561,206 $14.5 Million
Q1 2021 May 17, 2021	BUY	$28.0 - $53.42 $15.2 Million - $29 Million	542,912 New	542,912 $22.6 Million

146

67.6M

612K

118K

Ticker CGEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,612,200
Market Cap $499M
Description
Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

Stay updated on Woodline Partners LP with notifications on news.